1 active not recruiting, 1 completed, 1 recruiting, 1 terminated. 4 Phase 2, 2 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Active not recruiting 1, Completed 1, Recruiting 1, Terminated 1 |
| Phase 1 | 2 | Active not recruiting 1, Terminated 1 |
| Phase 3 | 1 | Completed 1 |
Follow Metastatic Tumor: new trials by email Literature Review of Metastatic Tumor trials Research Report on Metastatic Tumor
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Definitive Radiation for High-Risk Spine Metastases SBRT to the spine - Metastatic Cancer, Metastatic Lung Cancer | Phase 2 | Recruiting | Stony Brook University | 26 | 2023-12-14 | 2025-05-14 |
| Study Evaluating the Benefit of Adding Ipilimumab to the Combination of Atezolizumab and Bevacizumab in Patients With Hepatocellular Carcinoma Receiving First-line Systemic Therapy Ipilimumab Injection, Atezolizumab Injection, Bevacizumab - HCC - Hepatocellular Carcinoma, Metastatic Cancer | Phase 2 / Phase 3 | Completed | Federation Francophone de Cancerologie Digestive | 229 | 2023-03-09 | 2026-03-09 |
| A First-in-Human, Phase 1 Study of TST003 in Subjects With Solid Tumors TST003 - Locally Advanced Solid Tumor, Metastatic Tumor | Phase 1 / Phase 2 | Active not recruiting | Transcenta Therapeutics (Hangzhou) Co., Ltd. | 111 | 2023-02-08 | 2026-09-29 |
| Safety, Tolerability, and Anti-Tumor Activity of AFM24 in Combination With SNK01 in Subjects With Advanced/Metastatic EGFR-Expressing Cancers AFM24, SNK01 - Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung | Phase 1 / Phase 2 | Terminated | NKGen Biotech, Inc. | 11 | 2021-11-03 | 2024-03-01 |
Neoplasm Metastasis (4) · Lung Neoplasms (2) · Bone Neoplasms (1) · Breast Neoplasms (1) · Carcinoma, Hepatocellular (1) · Carcinoma, Non-Small-Cell Lung (1) · Colorectal Neoplasms (1) · Neoplasms (1) · Squamous Cell Carcinoma of Head and Neck (1)
Neoplastic Processes (4) · Pathologic Processes (4) · Pathological Conditions, Signs and Symptoms (4) · Neoplasms (3) · Neoplasms by Site (3) · Carcinoma (2) · Digestive System Diseases (2) · Digestive System Neoplasms (2) · Lung Diseases (2) · Neoplasms by Histologic Type (2) · Neoplasms, Glandular and Epithelial (2) · Respiratory Tract Diseases (2) · Respiratory Tract Neoplasms (2) · Thoracic Neoplasms (2) · Adenocarcinoma (1)
Bevacizumab (1) · Ipilimumab (1) · atezolizumab (1)
Federation Francophone de Cancerologie Digestive (1) · NKGen Biotech, Inc. (1) · Stony Brook University (1) · Transcenta Therapeutics (Hangzhou) Co., Ltd. (1)
United States (3) · France (1)
Kartik Mani, MD PhD (1) · Paul Chang, MPH (1)